The October 2023 NTI Board of Directors dinner featured a panel discussion about the implications of AI technologies for nuclear and biosecurity with Under Secretary for Nuclear Security at the Department of Energy (DOE) and Administrator of the National Nuclear Security Administration (NNSA) Jill Hruby and Twist Bioscience Co-founder and CEO Emily Leproust. The discussion was moderated by Washington Post columnist David Ignatius, with opening remarks by NTI Co-Chair and CEO Ernest J. Moniz.